Targeted binding agents directed to alpha5beta1 and uses thereof

Details for Australian Patent Application No. 2009331528 (hide)

Owner AstraZeneca AB

Inventors Eberlein, Catherine Anne; Foltz, Ian; Kang, Paul; Kendrew, Jane; Alfred, Avril; Barry, Simon Thomas

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009331528

PCT Pub. Number WO2010/072740

Priority 60/140,331 23.12.08 US

Filing date 21 December 2009

Wipo publication date 1 July 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/072740 Priority application(s): WO2010/072740

18 August 2011 Amendment Made

  The nature of the amendment is: Amend the priority details to read 61/140,331 23 Dec 2008 US 2009334249 Daikin Industries, Ltd. The nature of the amendment is: Amend the invention title to read Air conditioning apparatus and method of controlling the air conditioning apparatus

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009331529-Targeted binding agents directed to alpha5beta1 and uses therefor

2009331526-Polyunsaturated fatty acid and diol ester as an anti-acne agent